Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Mesenchymal Stem Cell Infusion for Treatment Of Steroid Resistant GVHD

NCT00749164 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00749164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00749164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Mesenchymal Stem Cell Infusion for Treatment Of Steroid Resistant GVHD
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2009
Completion date
August 31, 2012
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease